<amendment session="108" chamber="s" number="981" updated="2022-02-03T04:58:55Z">
  <amends type="s" number="1" sequence=""/>
  <status datetime="2003-06-23">offered</status>
  <sponsor bioguide_id="P000590"/>
  <offered datetime="2003-06-23"/>
  <description>To provide equal access to competitive global prescription medicine prices for American purchasers.</description>
  <actions>
    <action datetime="2003-06-24">
      <text>Motion to table amendment SA 981 agreed to in Senate by Yea-Nay Vote. 66 - 31. Record Vote Number: 235.</text>
    </action>
    <action datetime="2003-06-24">
      <text>Considered by Senate.</text>
      <reference ref="CR S8386, S8403" label="consideration"/>
    </action>
    <action datetime="2003-06-23">
      <text>Amendment SA 981 proposed by Senator Pryor. (consideration: CR S8331-8335, S8341- 8393; text: CR S8331-8332) To provide equal access to competitive global prescription medicine prices for American purchasers.</text>
    </action>
    <action datetime="2003-06-24">
      <text>Roll call votes on amendments in Senate: Motion to table amendment SA 981 agreed to in Senate by Yea-Nay Vote. 66 - 31. Record Vote Number: 235.</text>
    </action>
    <action datetime="2003-06-23">
      <text>Senate amendment proposed (on the floor): Amendment SA 981 proposed by Senator Pryor.</text>
      <reference ref="CR S8331-8335, S8341- 8393" label="consideration"/>
      <reference ref="CR S8331-8332" label="text"/>
    </action>
    <action datetime="2003-06-23">
      <text>Senate amendment submitted</text>
    </action>
  </actions>
</amendment>
